Holdings of ARK Genomic Revolution ETF
ARK ETF Trust · 32 declared positions · as of Apr 30, 2026
Original filing · Net assets 1.2B $ · Ten largest lines: 59 % of the equity sleeve
Sector breakdown
- Health care 1.0 %
- Unattributed 99.0 %
Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.
Currency breakdown
- USD 100.0 %
The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.
Country breakdown
- US 87.5 %
- CH 8.9 %
- GB 2.4 %
- DE 1.1 %
Shares computed on the equity sleeve, the only part this site carries.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 29 | 1.1B $ | 87.54 % |
| CH | 1 | 110.1M $ | 8.95 % |
| GB | 1 | 30M $ | 2.44 % |
| DE | 1 | 13.1M $ | 1.07 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Tempus AI Inc | 2,098,455 | 116.4M $ | 9.42 % |
| Twist Bioscience Corp | 1,900,539 | 111.1M $ | 8.99 % |
| CRISPR Therapeutics AG | 2,103,707 | 110.1M $ | 8.91 % |
| 10X Genomics Inc | 3,232,541 | 71.3M $ | 5.77 % |
| Beam Therapeutics Inc | 2,212,153 | 67.1M $ | 5.43 % |
| Absci Corp | 11,876,202 | 59.1M $ | 4.78 % |
| Natera Inc | 243,718 | 50.2M $ | 4.07 % |
| Illumina Inc | 392,835 | 49.8M $ | 4.03 % |
| Intellia Therapeutics Inc | 3,498,399 | 47.2M $ | 3.82 % |
| Personalis Inc | 8,017,242 | 44.3M $ | 3.58 % |
| Recursion Pharmaceuticals Inc | 12,549,240 | 43.4M $ | 3.51 % |
| Guardant Health Inc | 496,000 | 43.2M $ | 3.49 % |
| CareDx Inc | 2,009,757 | 41.8M $ | 3.38 % |
| Veracyte Inc | 999,975 | 32.9M $ | 2.66 % |
| Compass Pathways plc | 3,316,076 | 30M $ | 2.43 % |
| Adaptive Biotechnologies Corp | 2,123,561 | 29.9M $ | 2.42 % |
| Nurix Therapeutics Inc | 1,723,734 | 28.8M $ | 2.33 % |
| GeneDx Holdings Corp | 401,292 | 25.2M $ | 2.04 % |
| Schrodinger Inc/United States | 2,093,199 | 25M $ | 2.03 % |
| Arcturus Therapeutics Holdings Inc | 2,809,043 | 24.2M $ | 1.96 % |
| Butterfly Network Inc | 4,889,029 | 23.4M $ | 1.89 % |
| Ionis Pharmaceuticals Inc | 288,230 | 21.5M $ | 1.74 % |
| AtaiBeckley Inc | 4,382,604 | 18.2M $ | 1.48 % |
| Prime Medicine Inc | 4,925,864 | 17.5M $ | 1.41 % |
| Pacific Biosciences of California Inc | 10,964,895 | 17.4M $ | 1.41 % |
| Cerus Corp | 7,450,534 | 15.1M $ | 1.22 % |
| Alamar Biosciences Inc | 596,585 | 14.9M $ | 1.21 % |
| 908 Devices Inc | 1,952,552 | 13.3M $ | 1.08 % |
| BioNTech SE | 126,929 | 13.1M $ | 1.06 % |
| Eli Lilly & Co | 12,571 | 11.7M $ | 0.95 % |
| Quantum-Si Inc | 6,928,343 | 6.8M $ | 0.55 % |
| Generate Biomedicines Inc | 503,531 | 6.4M $ | 0.51 % |